Genetic testing and management of prostate cancer patients with pathogenic germline variants
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Genetic testing and management of prostate cancer patients with pathogenic germline variants ; day:3 ; month:11 ; year:2023 ; pages:1-6
Magazine of European Medical Oncology ; (3.11.2023), 1-6
- Creator
-
Reiter, Katharina
Hassler, Melanie R.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12254-023-00921-1
- URN
-
urn:nbn:de:101:1-2024012212170917140369
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reiter, Katharina
- Hassler, Melanie R.
- SpringerLink (Online service)
Other Objects (12)
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes
Prevalence of pathogenic germline variants in the circulating tumor DNA testing
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing
Beyond germline genetic testing - heterozygous pathogenic variants in PMS2 in two children with osteosarcoma and ependymoma
Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study
Clinically significant germline pathogenic variants are missed by tumor genomic sequencing
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes
Performance of clinical risk scores and prediction models to identify pathogenic germline variants in patients with advanced prostate cancer
Potential pathogenic germline variant reporting from tumor comprehensive genomic profiling complements classic approaches to germline testing
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands
Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome
Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer